Your browser doesn't support javascript.
Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: The International Cancer Screening Network COVID-19 survey.
Puricelli Perin, Douglas M; Elfström, K Miriam; Bulliard, Jean-Luc; Burón, Andrea; Campbell, Christine; Flugelman, Anath A; Giordano, Livia; Kamineni, Aruna; Ponti, Antonio; Rabeneck, Linda; Saraiya, Mona; Smith, Robert A; Broeders, Mireille J M.
  • Puricelli Perin DM; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA. Electronic address: douglas.puricelliperin@nih.gov.
  • Elfström KM; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Regional Cancer Center of Stockholm Gotland, Stockholm, Sweden.
  • Bulliard JL; Center for Primary Care and Public Health (unisanté), University of Lausanne, Lausanne, Switzerland.
  • Burón A; Epidemiology and Evaluation Department, Hospital del Mar, Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; REDISSEC (Health Services Research on Chronic Patients Network), Madrid, Spain.
  • Campbell C; Usher Institute, University of Edinburgh, Scotland, UK.
  • Flugelman AA; Department of Community Medicine and Epidemiology, Lady Davis Carmel Medical Center, Haifa, Israel; Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; Clalit National Cancer Control Center, Haifa, Israel.
  • Giordano L; SSD Epidemiologia e screening - CPO, University Hospital 'Città della Salute e della Scienza', Turin, Italy.
  • Kamineni A; Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
  • Ponti A; SSD Epidemiologia e screening - CPO, University Hospital 'Città della Salute e della Scienza', Turin, Italy.
  • Rabeneck L; Prevention and Cancer Control, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Saraiya M; Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Smith RA; American Cancer Society, Atlanta, GA, USA.
  • Broeders MJM; Radboud university medical center, Radboud Institute for Health Sciences, Nijmegen, the Netherlands; Dutch Expert Centre for Screening, Nijmegen, the Netherlands.
Prev Med ; 151: 106642, 2021 10.
Article in English | MEDLINE | ID: covidwho-1294330
ABSTRACT
Screening can decrease the burden of breast, cervical, and colorectal cancers. The COVID-19 pandemic led many countries to suspend cancer screening services as part of their response to the pandemic. The International Cancer Screening Network (ICSN) carried out an online survey to assess the effects of the first wave of the COVID-19 pandemic on cancer screening. A 33-item survey was distributed to 834 email addresses to gather information about settings and assess decision-making processes that led to cancer screening suspension. Information about communication, impact on resources, and patient follow-up was collected. Quantitative data was analyzed as frequencies overall and by setting, while a comment section under each survey item captured nuanced details. Responses were recategorized into 66 settings, representing 35 countries. Most settings suspended cancer screening services (n = 60, 90.9%) in March 2020 (n = 45, 68.2%), guided by a government decision (n = 51, 77.3%). Few settings made the decision whether to suspend services based on a preparedness plan (n = 17, 25.8%). In most settings, professionals were reassigned (n = 41, 62.1%) and infrastructure repurposed (n = 35, 53.0%). The first wave of the COVID-19 pandemic has had profound effects on cancer screening worldwide, including the suspension of services in almost all settings. Most settings were unprepared to deal with the scale of the pandemic but demonstrated flexibility in the response. These results contribute to inform, through experiences and lessons learned, the next steps for the global cancer screening community to further evaluate the impact of COVID-19 and prepare for future disruptions.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Diagnostic study / Prognostic study / Randomized controlled trials / Screening study Limits: Humans Language: English Journal: Prev Med Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Diagnostic study / Prognostic study / Randomized controlled trials / Screening study Limits: Humans Language: English Journal: Prev Med Year: 2021 Document Type: Article